Laboratory Studies
Postnatal rubella
A clinical diagnosis of rubella may be difficult to make because many exanthematic diseases may mimic rubella infection. In addition, as many as 50% of rubella infections may be subclinical; therefore, laboratory studies are important to confirm the diagnosis of acute rubella infection.
The laboratory diagnosis of rubella can be made either though serologic testing or by viral culture. The serologic diagnosis consists of demonstrating the presence of rubella-specific immunoglobulin M (IgM) antibody in a single serum sample or observation of a significant (>4-fold) rise in rubella-specific immunoglobulin G (IgG) antibody titer between the acute and convalescent serum specimens drawn 2-3 weeks apart.
False-positive rubella IgM test results have been reported in persons with other viral infections (eg, acute Epstein-Barr virus [EBV], infectious mononucleosis, cytomegalovirus [CMV] infection, parvovirus B19 infection) and in the presence of rheumatoid factor (RF).
To demonstrate a 4-fold rise in rubella-specific IgG antibody, a serum sample should be obtained as soon as possible during the acute phase of infection and tested for rubella-specific IgG antibody. An aliquot of this serum should be frozen and stored for repeat testing later. Then, a second serum specimen is collected at 2-3 weeks and tested in the same laboratory at the same time with the first serum sample. The levels of rubella-specific IgG are compared between the first and the second sample to show a significant rise in antibody titers.
Several techniques are available for serologic testing, including the following:
- Enzyme-linked immunosorbent assay (ELISA)
- Immunofluorescent assay (IFA)
- Latex agglutination (LA) test
- Hemagglutination inhibition (HI) test
- Complement fixation (CF) test
- Passive hemagglutination antibody (PHA) test
- Hemolysis-in-gel test
Among all the serologic tests available, ELISA is the most widely used because it is relatively inexpensive, technically easy to perform, rapid, and very sensitive.
Rubella viral cultures are time consuming, expensive, not readily available, and used mainly for tracking the epidemiology of rubella virus during an outbreak.
The most commonly used method for isolation of rubella virus from clinical specimens, taken from an infected person, is the interference technique using African green monkey kidney (AGMK) cells and an enterovirus.
The specimen (urine or nasopharyngeal swab) is inoculated onto primary AGMK monolayers. After 9-12 days, the cultures are challenged with an enterovirus. If rubella is present, it interferes with the challenge virus and no cytopathic effect (CPE) is observed on the AGMK cells. HI, CF, and immunofluorescence techniques have also been used to detect rubella-specific antigens in tissue culture.
Congenital rubella
Congenital rubella in infants and children is diagnosed by viral isolation or by serologic testing. In contrast to postnatal infection, viral isolation is the preferred technique in congenital rubella syndrome because rubella serology may be difficult to interpret in view of transplacental passage of rubella-specific maternal IgG antibody. In addition, rubella-specific IgM antibody may not be detectable at the time of evaluation. Congenital rubella syndrome has also been diagnosed using placental biopsy, rubella antigen detection by monoclonal antibody, and polymerase chain reaction (PCR).
Specimens used for viral isolation in congenital rubella include nasopharyngeal swab, urine, cerebrospinal fluid, and buffy coat of the blood.
In some infants with congenital rubella syndrome, rubella virus can persist and can be isolated from the nasopharyngeal and urine cultures throughout the first year of life or later.
The same serologic testing methods (ELISA, IFA, LA, HI, CF) discussed for postnatal rubella can be used to detect specific antibodies in congenital infection.
Rubella-specific IgM antibody is actively produced by the fetus or neonate and may be detected in the cord blood or neonatal serum.
Congenital rubella syndrome should be strongly suspected in infants older than 3 months if rubella-specific IgG antibody levels are observed and do not decline at the rate expected from passive transfer of maternal antibody (ie, equivalent of a 2-fold decline in HI titer per mo) in a compatible clinical situation.
Patients with concomitant immunodeficiency, such as agammaglobulinemia or dysgammaglobulinemia, may have a false-negative serology result for rubella. Therefore, viral isolation is required to confirm the diagnosis in this group of patients.
Imaging Studies
Postnatal rubella
Imaging studies are usually not performed in postnatal rubella.
Congenital rubella syndrome
Chest radiography is indicated for infants who develop respiratory distress or other respiratory symptoms to exclude rubella-related interstitial pneumonitis or pulmonary edema that may result from congestive heart failure in children with severe or complicated congenital heart anomalies.
Radiography of the long bones may reveal radiolucencies in the metaphyses of long bones.
Echocardiography is important for patients with congenital heart defects to help diagnose the type of heart anomaly and evaluate the severity of the heart defect so that appropriate surgical plans can be made.
CT scanning of the head may reveal intracranial calcifications and enlargement of the ventricles.
MRI of the head may reveal cortical atrophy and white matter changes in patients with late-onset progressive panencephalitis.
Other Tests
CBC count may reveal leukopenia and thrombocytopenia. It is used to monitor the course of thrombocytopenia.
Liver function tests, such as total and direct bilirubin, alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, and gamma-glutamyl transpeptidase levels may reveal hepatic injury due to disseminated rubella infection, especially in neonates.
Procedures
Lumbar puncture is indicated to evaluate for possible causes in children who develop signs and symptoms of meningoencephalitis, such as full anterior fontanelle, irritability, hypotonia, seizures, lethargy, head retraction, and arching of the back.
In patients with rubella-related meningoencephalitis, CSF examination usually reveals normal glucose levels, normal or slightly elevated protein levels, and mild pleocytosis (20-100 WBC/mcL) with lymphocyte predominance.
Histologic Findings
Postnatal rubella
Histologically cutaneous lesions are nonspecific and demonstrate only a mild, superficial, perivascular, lymphocytic infiltrate.
Congential rubella
The gross neuropathologic features that present during autopsy of babies who are stillborn include microcephaly and various other malformations (ie, polymicrogyria, nonhemorrhagic subependymal germinal matrix cysts). Histologically, chronic inflammatory cells are found in the meninges and surrounding the intraparenchymal blood vessels. The vessel walls also show foci of subintimal fibrosis and mineralization.
Pandolfi E, Chiaradia G, Moncada M, Rava L, Tozzi AE. Prevention of congenital rubella and congenital varicella in Europe. Euro Surveill. Mar 5 2009;14(9):16-20. [Medline].
CDC. Summary of notifiable diseases, United States, 1996. MMWR Morb Mortal Wkly Rep. Oct 31 1997;45(53):1-87. [Medline].
CDC. Reported Cases of Notifiable Diseases-United States, 1972-2003. MMWR. Apr 2005;52(54):73-78.
CDC. Provisional cases of infrequently reported notifiable diseases. MMWR. January 9, 2009;57(53):1420-1431.
CDC. Provisional Cases of Infrequently Reported Notifiable Diseases-United States. MMWR. Jan 2009;55(19):538.
Institute for Clinical Systems Improvement. Immunizations. Bloomington, MN: ICSI; 2008.
Klein NP, Fireman B, Yih WK, Lewis E, Kulldorff M, Ray P, et al. Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures. Pediatrics. Jul 2010;126(1):e1-8. [Medline].
Hviid A. Measles-mumps-rubella-varicella combination vaccine increases risk of febrile seizure. J Pediatr. Jan 2011;158(1):170. [Medline]. [Full Text].
[Guideline] Marin M, Broder KR, Temte JL, Snider DE, Seward JF. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. May 7 2010;59:1-12. [Medline]. [Full Text].
American Academy of Pediatrics; Committee on Infectious Diseases. Policy Statement--Prevention of Varicella: Update of Recommendations for Use of Quadrivalent and Monovalent Varicella Vaccines in Children. Pediatrics. Aug 28 2011;[Medline].
Dontigny L, Arsenault MY, Martel MJ, et al. Rubella in pregnancy. J Obstet Gynaecol Can. Feb 2008;30(2):152-68. [Medline].
American Academy of Pediatrics. 2003 Red Book: Report of the Committee on Infectious Diseases. 26th ed. American Academy of Pediatrics; 2003.
Bale JF Jr, Murph JR. Congenital infections and the nervous system. Pediatr Clin North Am. Aug 1992;39(4):669-90. [Medline].
Bialecki C, Feder HM Jr, Grant-Kels JM. The six classic childhood exanthems: a review and update. J Am Acad Dermatol. Nov 1989;21(5 Pt 1):891-903. [Medline].
Bullens D, Smets K, Vanhaesebrouck P. Congenital rubella syndrome after maternal reinfection. Clin Pediatr (Phila). Feb 2000;39(2):113-6. [Medline].
CDC. Elimination of rubella and congenital rubella syndrome--United States, 1969-2004. MMWR Morb Mortal Wkly Rep. Mar 25 2005;54(11):279-82. [Medline].
CDC. Progress toward elimination of measles and prevention of congenital rubella infection--European region, 1990-2004. MMWR Morb Mortal Wkly Rep. Feb 25 2005;54(7):175-8. [Medline].
CDC. Quarterly immunization table. MMWR. July 1997.
CDC. Reportable diseases (1998 provisional data). MMWR. 2000;48:1183-89.
CDC. Rubella among Hispanic adults--Kansas, 1998, and Nebraska, 1999. MMWR Morb Mortal Wkly Rep. Mar 24 2000;49(11):225-8. [Medline].
CDC. Rubella outbreak--Westchester County, New York, 1997-1998. MMWR Morb Mortal Wkly Rep. Jul 9 1999;48(26):560-3. [Medline].
Cherry JD. Contemporary infectious exanthems. Clin Infect Dis. February 1993;16(2):199-205. [Medline].
Cherry JD. Rubella virus. In: Feigin RD, Cherry JD, eds. Textbook of Pediatric Infectious Diseases. Vol 2. 4th ed. WB Saunders Co; 1998:1922-49.
Cherry JD. Viral exanthems. Curr Probl Pediatr. Apr 1983;13(6):1-44. [Medline].
Editorial. TORCH syndrome and TORCH screening. Lancet. Jun 30 1990;335(8705):1559-61. [Medline].
Englund J, Glezen WP, Piedra PA. Maternal immunization against viral disease. Vaccine. August-September 1998;16(14-15):1456-1463. [Medline].
Freij BJ, South MA, Sever JL. Maternal rubella and the congenital rubella syndrome. Clin Perinatol. Jun 1988;15(2):247-57. [Medline].
Giles CL. Uveitis in childhood - Part III Posterior. Ann Ophthalmol. January 1989;21(1):23-28. [Medline].
Gold E. Almost extinct diseases: measles, mumps, rubella, and pertussis. Pediatr Rev. Apr 1996;17(4):120-7. [Medline].
Horstmann DM. Rubella. In: Evans AS, ed. Viral Infections of Humans, Epidemiology and Control. 3rd ed. Premium Medical Book Co; 1991:617-30.
Kimberlin DW. Rubella immunization. Pediatr Ann. Jun 1997;26(6):366-70. [Medline].
Lindegren ML, Fehrs LJ, Hadler SC, Hinman AR. Update: rubella and congenital rubella syndrome, 1980-1990. Epidemiol Rev. 1991;13:341-8. [Medline].
Lutwick LI. Postexposure prophylaxis. Infect Dis Clin North Am. Dec 1996;10(4):899-915. [Medline].
Maldonado YA. Rubella virus. In: Long SS, Pickering LK, Prober CG, eds. Principles and Practice of Pediatric Infectious Diseases. Churchill Livingstone; 1997:1228-37.
Miller E. Rubella reinfection. Arch Dis Child. Aug 1990;65(8):820-1. [Medline].
Morgan-Capner P. Diagnosing rubella. BMJ. Aug 5 1989;299(6695):338-9. [Medline].
Munoz FM, Englund JA. A step ahead. Infant protection through maternal immunization. Pediatr Clin North Am. Apr 2000;47(2):449-63. [Medline].
Parkman PD. Making vaccination policy: the experience with rubella. Clin Infect Dis. Jun 1999;28 Suppl 2:S140-6. [Medline].
Powell S, Schochet SS Jr. Selected pediatric viral infections. Semin Pediatr Neurol. Sep 1995;2(3):211-9. [Medline].
Reef S, Zimmerman-Swain L, Coronado V. Rubella. In: VPD Surveillance Manual. 1999:11.
Robinson J, Lemay M, Vaudry WL. Congenital rubella after anticipated maternal immunity: two cases and a review of the literature. Pediatr Infect Dis J. Sep 1994;13(9):812-5. [Medline].
Rosa C. Rubella and rubeola. Semin Perinatol. Aug 1998;22(4):318-22. [Medline].
Watson JC, Hadler SC, Dykewicz CA, et al. Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. May 22 1998;47(RR-8):1-57. [Medline].
Webster WS. Teratogen update: congenital rubella. Teratology. Jul 1998;58(1):13-23. [Medline].
Weiter JJ, Roh S. Viral infections of the choroid and retina. Infect Dis Clin North Am. Dec 1992;6(4):875-91. [Medline].
Wharton M, Cochi SL, Williams WW. Measles, mumps, and rubella vaccines. Infect Dis Clin North Am. Mar 1990;4(1):47-73. [Medline].
- Table 1. Reported Cases of Rubella, Deaths From Rubella, and Number of Cases of Congenital Rubella Syndrome in the United States From 1969-2007[2, 3, 4, 5]
- Table 2. Clinicopathologic Abnormalities in Congenital Rubella
- Table 3. Age-Specific CD4+ T-lymphocyte Count and Percentage of Total Lymphocytes as a Criteria for Severe Immunosuppression in Persons with HIV
| Year | Number of Cases | Number of Deaths | Cases of Congenital Rubella Syndrome |
| 1969 | 57,686 | 29 | 31 |
| 1970 | 56,552 | 31 | 77 |
| 1971 | 45,086 | 20 | 68 |
| 1972 | 25,507 | 14 | 42 |
| 1973 | 27,804 | 16 | 35 |
| 1974 | 11,917 | 15 | 45 |
| 1975 | 16,652 | 21 | 30 |
| 1976 | 12,491 | 12 | 30 |
| 1977 | 20,395 | 17 | 23 |
| 1978 | 18,269 | 10 | 30 |
| 1979 | 11,795 | 1 | 62 |
| 1980 | 3,904 | 1 | 50 |
| 1981 | 2,077 | 5 | 19 |
| 1982 | 2,325 | 4 | 7 |
| 1983 | 970 | 3 | 22 |
| 1984 | 752 | 1 | 5 |
| 1985 | 630 | 1 | 0 |
| 1986 | 551 | 1 | 5 |
| 1987 | 306 | 0 | 5 |
| 1988 | 225 | 1 | 6 |
| 1989 | 396 | 4 | 3 |
| 1990 | 1,125 | 8 | 11 |
| 1991 | 1,401 | 1 | 47 |
| 1992 | 160 | 1 | 11 |
| 1993 | 192 | 0 | 5 |
| 1994 | 227 | 0 | 7 |
| 1995 | 128 | 1 | 6 |
| 1996 | 238 | 0 | 4 |
| 1997 | 181 | 0 | 5 |
| 1998 | 364 | 0 | 7 |
| 1999 | 267 | 0 | 9 |
| 2000 | 176 | 0 | 9 |
| 2001 | 23 | 2 | 3 |
| 2002 | 18 | N/A | 1 |
| 2003 | 7 | N/A | 1 |
| 2004 | 10 | N/A | 0 |
| 2005 | 11 | N/A | 1 |
| 2006 | 11 | N/A | 1 |
| 2007 | 12 | N/A | 0 |
| Abnormality | Common/Uncommon | Early/Delayed | Comment |
| General | |||
| Intrauterine growth retardation | Common | Early | ... |
| Prematurity | Uncommon | Early | ... |
| Stillbirth | Uncommon | Early | ... |
| Abortion | Uncommon | Early | ... |
| Cardiovascular system | |||
| Patent ductus arteriosus | Common | Early | May occur with pulmonary artery stenosis |
| Pulmonary artery stenosis | Common | Early | Caused by intimal proliferation |
| Coarctation of the aorta | Uncommon | Early | ... |
| Myocarditis | Uncommon | Early | ... |
| Ventricular septal defect | Uncommon | Early | ... |
| Atrial septal defect | Uncommon | Early | ... |
| Eye | |||
| Cataract | Common | Early | Unilateral or bilateral |
| Retinopathy | Common | Early | Salt-and-pepper appearance; visual acuity unaffected; frequently unilateral |
| Cloudy cornea | Uncommon | Early | Spontaneous resolution |
| Glaucoma | Uncommon | Early/Delayed | May be bilateral |
| Microphthalmia | Common | Early | Common in patients with unilateral cataract |
| Subretinal neovascularization | Uncommon | Delayed | Retinopathy with macular scarring and loss of vision |
| Ear | |||
| Hearing loss | Common | Early/Delayed | Usually bilateral; mostly sensorineural; may be central in origin; rare when maternal rubella occurs >4 months' gestation; sometimes progressive |
| CNS | |||
| Meningoencephalitis | Uncommon | Early | Transient |
| Microcephaly | Uncommon | Early | May be associated with normal intelligence |
| Intracranial calcifications | Uncommon | Early | ... |
| Encephalographic abnormalities | Common | Early | Usually disappear by age 1 y |
| Mental retardation | Common | Delayed | ... |
| Behavioral disorders | Common | Delayed | Frequently related to deafness |
| Autism | Uncommon | Delayed | ... |
| Chronic progressive panencephalitis | Uncommon | Delayed | Manifest in second decade of life |
| Hypotonia | Uncommon | Early | Transitory defect |
| Speech defects | Common | Delayed | Uncommon in absence of hearing loss |
| Skin | |||
| Blueberry muffin spots | Uncommon | Early | Represents dermal erythropoiesis |
| Chronic rubelliform rash | Uncommon | Early | Usually generalized; lasts several weeks |
| Dermatoglyphic abnormalities | Common | Early | ... |
| Lungs | |||
| Interstitial pneumonia | Uncommon | Delayed | Generalized; probably immunologically mediated |
| Liver | |||
| Hepatosplenomegaly | Common | Early | Transient |
| Jaundice | Uncommon | Early | Usually appears in the first day of life |
| Hepatitis | Uncommon | Early | May not be associated with jaundice |
| Blood | |||
| Thrombocytopenia | Common | Early | Transient; no response to steroid therapy |
| Anemia | Uncommon | Early | Transient |
| Hemolytic anemia | Uncommon | Early | Transient |
| Altered blood group expression | Uncommon | Early | ... |
| Immune system | |||
| Hypogammaglobulinemia | Uncommon | Delayed | Transient |
| Lymphadenopathy | Uncommon | Early | Transient |
| Thymic hypoplasia | Uncommon | Early | Fatal |
| Bone | |||
| Radiographic lucencies | Common | Early | Transient; most common in distal femur and proximal tibia |
| Large anterior fontanel | Uncommon | Early | ... |
| Micrognathia | Uncommon | Early | ... |
| Endocrine glands | |||
| Diabetes mellitus | Common | Delayed | Usually becomes apparent in second or third decade of life |
| Thyroid disease | Uncommon | Delayed | Hypothyroidism, hyperthyroidism, and thyroiditis |
| Growth hormone deficiency | Uncommon | Delayed | ... |
| Genitourinary system | |||
| Cryptorchidism | Uncommon | Early | ... |
| Polycystic kidney | Uncommon | Early | ... |
| Age Range | ||||
| < 12 mo | 1-5 y | 6-12 y | ≥13 y | |
| Total CD4+ T-lymphocytes | < 750/mcl | < 500/mcl | < 200/mcl | < 200/mcl |
| CD4+ T-lymphocytes (as % of total lymphocytes) | < 15% | < 15% | < 15% | < 14% |

